Table 1 Pre-treatment blood results of 2 patients
Variable | Value | Reference value | |
|---|---|---|---|
Patient 1 | Patient 2 | ||
Hematology | |||
 Leukocytes | 5.55 × 10^9/L | 8.05 × 10^9/L | 3.5–9.5 × 10^9/L |
 Neutrophil | 59.60% | 57.30% | 40–75% |
 Lymphocyte | 27.40% | 20.70% | 20–50% |
 Monocyte | 6.50% | 6.60% | 3–10% |
 Eosinophils | 6.50% | 15.40% | 0.4–8.0% |
 Basophils | 0.00% | 0.00% | 0–1% |
 Erythrocytes | 5.49 × 10^12/L | 4.66 × 10^12/L | 3.8–5.8 × 10^12/L |
 Hemoglobin | 159 g/L | 143.0 g/L | 115-175 g/L |
 Hematocrit | 47.10% | 42.90% | 35–50% |
 Platelets | 190 × 10^9/L | 230 × 10^9/L | 125–350 × 10^9/L |
Blood chemistry | |||
 AST | 83.00 U/L | 182.00 U/L | 13–40 U/L |
 ALT | 236.00 U/L | 399.00 U/L | 7–50 U/L |
 γ-GTP | 848.00 U/L | 419.00 U/L | 10–60 U/L |
 Total bilirubin | 128.80 μmol/L | 129.20 μmol/L | 3-24 μmol/L |
 Direct bilirubin | 92.20 mmol/L | 96.90 mmol/L | 0–8.0 mmol/L |
 ALP | 315 U/L | 315 U/L | 45–125 U/L |
 TBA | 233.00 μmol/L | 242.90 μmol/L | 0–10 μmol/L |